Digital Health & HealthTech — India ↔ EU Trade Facilitation

Bilateral trade · India ↔ EU

What moves on this corridor.

India exports → EU

USD 1.8B digital health services annually — telemedicine platforms (second opinion services for EU patients: Apollo Hospitals, Narayana Health EU telemedicine); AI diagnostic tools (radiology AI — qure.ai, Niramai — for EU radiology departments); health data analytics platforms; clinical research services (IQVIA India, Parexel India — for EU pharma clinical trials); hospital management systems (HMS — Insta, Practo Practice Management); dental and ophthalmic device manufacturing for EU (with EU MDR certification)

Top India states: Karnataka (Bangalore — Practo, Niramai, qure.ai; AI health startup ecosystem), Maharashtra (Mumbai/Pune — Apollo Hospitals HQ, Tata Health, PharmEasy), Delhi NCR (Apollo Hospitals, Fortis, Max Health — digital health deployment), Tamil Nadu (Chennai — Narayana Health; dental device manufacturing), Telangana (Hyderabad — Health SRCity; pharma-digital health convergence)

EU exports → India

EUR 2.4B annually — EU medical device companies expanding India digital health footprint (Philips Healthcare India, Siemens Healthineers India, Roche Diagnostics India); EU telemedicine platforms (Doctolib — expanding beyond EU); EU hospital management software (SAP for Healthcare — India deployment); EU health data infrastructure advisory (for ABHA/NHA India interoperability); EU robotic surgery systems (Da Vinci — Intuitive Surgical, distributed by Indian hospitals)

Top EU buyers: Germany (largest EU health system; digital health investments — gematik eHealth infrastructure; German hospitals seeking AI diagnostic tools), Netherlands (Philips Healthcare HQ; Dutch health tech innovation ecosystem), France (HAS — French health authority digital health; Doctolib — France telemedicine champion), Nordic (Denmark, Sweden — highly digitalised health systems; eHealth interoperability leaders), Portugal (SNS Digital Transformation Plan; Portuguese health system seeking digital tools)

Growth rate

+23% CAGR India digital health (2019–2024) · Telemedicine +40% CAGR · AI diagnostics in India +55% CAGR · ABHA health ID adoption +200M/year

FTA duty impact

Digital health services are Mode 1 (telemedicine, remote diagnostics — 0%) and Mode 3 (commercial presence). Medical devices (physical) see duty reductions under FTA (EU MDR compliance required). AI diagnostic software: 0% (digital delivery, WTO Moratorium). EU AI Act: high-risk AI medical devices face conformity assessment requirements regardless of origin — applicable to Indian AI diagnostic tools deployed in EU.

HS codes & tariff rates

Tariff lines that matter.

HS code	Product	EU MFN	FTA rate
`Services (Mode 1)`	Telemedicine, remote diagnostics, health data analytics — digital delivery	0%	FTA digital chapter
`9018`	Medical instruments — electro-diagnostic apparatus, CT, MRI	0%	0% (MFN / ITA)
`9022`	X-ray apparatus and CT scanners	0%	0% (ITA)
`8543`	Electrical machines for medical purposes — robotic surgery components	0–2.5%	0% (Year 1 FTA)
`3005`	Medical dressings, wound care — digital health connected devices	0%	0%
`Services`	Clinical research, health data analytics — cross-border	0%	FTA Mode 1

HS codes and rates are indicative. Verify on EU TARIC before commercial use.

HS code lookup tool →

EU compliance

Required certifications.

EU Medical Device Regulation (EU MDR 2017/745) — Full Enforcement

EU MDR (full enforcement from May 2021 for new devices, legacy devices by May 2024/2026) is the defining compliance requirement for any medical device sold in EU. Three device classes: Class I (low risk — basic dressings), Class IIa/IIb (medium — most diagnostic devices), Class III (high risk — implants, life-sustaining). Indian HealthTech companies selling physical medical devices to EU MUST obtain EU MDR CE marking through an EU Notified Body (BSI, TÜV SÜD, DNV, SGS) — no exemptions for Indian origin.

EU MDR 2017/745 · Notified Body (BSI, TÜV SÜD) · EUDAMED · MDD legacy transition

EU IVDR (In Vitro Diagnostic Medical Devices Regulation 2017/746)

EU IVDR (full enforcement from May 2022 for Class D; May 2025 for Class C, 2026 for Class B) applies to all diagnostic devices that interact with human biological samples — blood glucose monitors, PCR tests, pregnancy tests, cancer biomarker tests. Indian IVD manufacturers (including diagnostics — Transasia Bio-Medicals, Trivitron, J Mitra) supplying EU must obtain IVDR CE marking — significantly more stringent than the previous IVDD requirements.

EU IVDR 2017/746 · Notified Body · EUDAMED IVD database

EU AI Act — High-Risk AI in Healthcare

EU AI Act (2024/1689) classifies AI systems used in healthcare as high-risk AI: AI for medical diagnosis, patient triage, disease prediction, radiology image analysis, pathology AI. Indian AI diagnostic companies (qure.ai — chest X-ray AI, Niramai — thermal imaging breast cancer AI) deploying EU face: conformity assessment, technical documentation, EU AI database registration, human oversight requirements, ongoing post-market monitoring.

EU AI Act 2024/1689 · EU AI Office · High-Risk AI annex III

GDPR — Special Category Health Data

Health data is a "special category" under GDPR Article 9 — subject to enhanced protection requirements. Indian telemedicine platforms and health data analytics companies processing EU patient health data must: (1) obtain explicit consent (not just legitimate interest); (2) implement SCCs for India-EU health data transfer; (3) conduct Data Protection Impact Assessment (DPIA) — mandatory for large-scale health data processing; (4) appoint EU Data Protection Representative.

GDPR Article 9 · DPIA guidance · SCCs for health data

India ABDM (Ayushman Bharat Digital Mission) Interoperability

India's ABHA (Ayushman Bharat Health Account) digital health ID system (560M+ registered) creates a health data infrastructure that EU health tech companies are studying for Europe's EHR interoperability challenges. EU Commission HealthData@EU initiative (2022) — for sharing health data across EU — is comparable in ambition to ABDM. Regulatory sandbox participation for EU companies studying ABDM is available through NHA (National Health Authority) India.

ABHA Health ID · NHA India · ABDM · HealthData@EU · EHDS (European Health Data Space)

EU compliance checker tool →

Bilateral trade flow

India ↔ EU · the directions.

India → EU (Digital Health Exports)

Telemedicine second opinion services (Apollo Hospitals, Narayana Health — EU patients seeking India specialist opinions for complex cases: cardiology, oncology, orthopaedics at 40–70% below EU specialist fee); AI diagnostic tools (qure.ai radiology AI — deployed in 65+ countries including EU — chest X-ray, ECG AI analysis); clinical research services (IQVIA India, Parexel India, Veeda Clinical Research — serving EU pharma and MedTech clinical trial programmes); hospital management software (Insta HMS, Practo Practice Management); dental devices (Trident Dental, Prime Dental — India dental manufacturer with EU MDR certification)

EU → India (Digital Health Exports)

Philips Healthcare India operations (ultrasound, patient monitoring, health informatics — expanding India digital health); Siemens Healthineers India (CT, MRI, PET — India imaging upgrade); Roche Diagnostics India (IVDR-class IVD instruments for India hospital labs); SAP for Healthcare India (hospital ERP — Apollo, Fortis SAP deployment); Da Vinci robotic surgery (Intuitive Surgical — India robotics expansion through EU-trained surgical teams)

Sector risk framework

Risks · assessment · mitigation.

Risk	Assessment	Mitigation
EU MDR CE marking absent — Indian medical device lacks EU notified body certification and cannot be sold in EU	High / Very High	Absolute — no EU MDR CE marking = no EU medical device sales. EU MDR certification: Class IIa (most diagnostics) — EUR 30,000–80,000 + 12–18 months. Class III (implants) — EUR 100,000–250,000 + 24–36 months. Plan certification timeline before EU market entry.
EU AI Act high-risk conformity assessment — Indian AI diagnostic tool not EU AI Act compliant	High / High	AI diagnostic tools (radiology AI, pathology AI, triage AI) are high-risk AI under EU AI Act Annex III. Conformity assessment required: technical documentation, GDPR DPIA, human oversight implementation, EU AI database registration. Timeline: 9–18 months for full AI Act compliance. Begin immediately for any EU AI diagnostic deployment.
GDPR special category health data breach — Indian telemedicine platform processes EU patient data without explicit consent	High / Very High	Health data requires explicit consent under GDPR Article 9 — legitimate interest basis is insufficient. Explicit consent must be: granular (specific to each processing purpose), informed (full transparency), freely given (no coercion), withdrawable. EU Data Protection Representative appointment is mandatory for Indian platforms with regular and systematic processing of EU patient data.

3 Ps · viability analysis

Possibility · probability · plausibility.

Possibility

Is this trade structurally viable?

Yes — India has world-class AI diagnostic tools (qure.ai deployed in 65+ countries), clinical research capability (IQVIA India — largest CRO by headcount globally), and low-cost specialist telemedicine. EU has healthcare workforce shortages, funding pressures, and active digital health investment agendas. The bilateral opportunity is commercially validated.

Probability

Will this specific mandate close?

High for telemedicine second opinion (no physical device — Mode 1, GDPR SCC required). High for clinical research (established EU pharma-India CRO relationships). Medium for AI diagnostic deployment (EU AI Act compliance timeline is the barrier). Medium for medical device physical export (EU MDR timeline and cost are the barrier).

Plausibility

Does the commercial logic hold?

Fully coherent. qure.ai, Niramai, and other Indian AI health companies already have EU deployments — the mandate is to scale these relationships and introduce new Indian health tech to EU healthcare buyers. India's 40–70% specialist consultation cost advantage in telemedicine creates a compelling case for EU patient access to Indian second opinions.

Marketing mix · 10P analysis

The vertical through a 10P lens.

Product

Telemedicine second opinion services (India specialist → EU patient); AI diagnostic tools (radiology, ECG, pathology, triage AI); clinical research services (CRO for EU pharma); hospital management software; medical device manufacturing with EU MDR certification; health data analytics; ABHA/digital health infrastructure advisory.

Price

Telemedicine: Indian specialist second opinion at EUR 150–500 vs EU EUR 400–1,200 (40–70% saving). AI diagnostic SaaS: 8–15% Year 1 ACV (EUR 30K–200K for EU radiology department). Clinical research: 8–12% contract value. Commission: 8–15% first-year contract for SaaS; 3–5% for clinical research services.

Place

India side: Bangalore (AI health startups), Mumbai (Apollo, PharmEasy), Hyderabad (clinical research, medtech manufacturing). EU side: Germany (largest EU health market — gematik, university hospitals), Netherlands (Philips ecosystem, Dutch health innovation), Portugal (SNS digitalisation — accessible market entry for Indian digital health).

Promotion

Arab Health Dubai (January — global health show; India health companies strong presence), MEDICA Düsseldorf (November — world's largest medical trade fair), Digital Health Congress Paris, India Digital Health Summit (annual, New Delhi), HLTH Europe (Barcelona — digital health startup conference).

People

Vinod Kumar Jain — India-side digital health company qualification, Apollo/Narayana/Practo network, CDSCO regulatory intelligence. Amit Jain — EU digital health investment landscape, EU MDR compliance advisory, EU AI Act health-risk classification, Portugal SNS digitalisation opportunity.

Process

Three P filter → EU MDR / IVDR certification status check → EU AI Act risk classification (if AI product) → GDPR SCC implementation → Mandate + NCNDA → EU hospital / health authority / health insurer buyer qualification → Pilot agreement → Commission on first-year ACV.

Physical Evidence

EU MDR CE certificate (Notified Body), EU AI Act conformity assessment documentation, GDPR DPIA, SCCs, CDSCO registration (India), ISO 13485 (medical device quality), commission invoice.

Partners

NHA (National Health Authority) India, FICCI Health Committee, ASSOCHAM Healthcare, Association of Diagnostics Manufacturers of India (ADMI), NATHEALTH — India. MedTech Europe, COCIR, European Hospital and Healthcare Federation (HOPE), European Connected Health Alliance (ECHAlliance) — EU.

Performance

Target: 3–5 digital health mandates per year. Commission: EUR 20,000–100,000 per mandate (8–15% on EUR 150K–750K Year 1 ACV for SaaS; 3–5% on EUR 500K–2M for clinical research). EU MDR-certified Indian device mandates generate the highest commission per transaction.

Purpose

Healthcare is the most personal of all trade verticals — connecting Indian AI that can read a chest X-ray in 2 seconds to the EU radiologist who faces a 6-week reporting backlog, or the EU patient who needs a specialist second opinion they cannot afford, is a mandate of genuine social as well as commercial value. Commission-only means the Indian health company pays only when the EU contract is signed.

Practitioner intelligence

What works · what doesn't.

✓ Success conditions

What works

✓ Positioning qure.ai and comparable Indian AI diagnostic tools as EU radiologist productivity solutions (not competition) — EU radiologists face 20–40% capacity shortfall; Indian AI that handles routine reads, flags critical findings, and reduces reporting backlog is a workflow solution, not a replacement threat
✓ Germany as the primary EU market for Indian AI diagnostic tools — German federal health IT investment (gematik, DiGA digital health applications) creates a government-backed procurement framework; DiGA (Digitale Gesundheitsanwendungen) certification enables Indian health apps to be prescribed by German doctors and reimbursed by public health insurance

✗ Failure modes

What doesn't work

✗ Attempting EU medical device sales without EU MDR certification — EU hospital procurement departments will not evaluate unregistered medical devices regardless of clinical evidence; EU MDR certification is the only valid market entry ticket and must be obtained before any EU medical device commercial activity
✗ Generic "health AI" pitches to EU hospital procurement — EU hospitals receive dozens of AI health vendor approaches weekly; the mandate must be specific: named clinical department, named clinical use case, evidence from peer-reviewed study or deployed EU reference site, EU AI Act risk classification pre-completed

Commission structure

How we get paid.

Deal type	Rate	Indicative value
AI diagnostic SaaS — Indian AI to EU radiology department	8–15% Year 1 ACV	EUR 30K–200K Year 1 · qure.ai / Niramai class AI
Telemedicine second opinion — India specialist to EU platform	8–12% Year 1 contract	EUR 20K–80K Year 1 · Apollo/Narayana specialist network
Clinical research — Indian CRO to EU pharma	5–8% contract value	EUR 100K–1M contract · IQVIA India, Veeda, Lotus CRS
Hospital management software — Indian HMS to EU hospital	8–12% Year 1 ACV	EUR 50K–200K Year 1 · Insta HMS, Practo Practice
Medical device (EU MDR certified) — India manufacturer to EU	3–5% supply value	EUR 200K–1M annual · dental, ophthalmic, consumables
Digital health advisory — ABDM/NHA India insights for EU	Fixed retainer EUR 15K–50K	EU government / health authority advisory on India model

Sub-specialisations

Niches we operate in.

Niche

AI Diagnostics (India → EU Radiology)

qure.ai, Niramai, Predible Health — Indian FDA-cleared / CE-marked AI diagnostic tools for EU radiology productivity.

8–15% Year 1 ACV

Niche

Telemedicine Second Opinion (India → EU Patient)

Apollo Hospitals, Narayana Health, Fortis — specialist second opinion at 40–70% below EU specialist cost.

8–12% Year 1 contract

Niche

German DiGA (Digital Health App — GKV Reimbursable)

Indian health apps seeking German DiGA certification (government reimbursement by all GKV statutory health insurers) — 70M+ insured covered.

8–12% Year 1 ACV

Niche

India CRO for EU Clinical Trials

IQVIA India, Parexel India, Veeda — India Phase II/III clinical research for EU pharma and MedTech at 40–60% below European CRO cost.

5–8% contract value

Active mandates · Digital Health & HealthTech

What's open right now.

SELL Indian AI radiology company (FDA-cleared, CE-marked Class IIa) — chest X-ray and CT triage AI, 65+ country deployments, seeking EU health system radiology department partnerships Bangalore / Mumbai → Germany / Netherlands / Portugal

BUY German university hospital (Universitätsklinikum) — seeking Indian AI diagnostic platform for radiology reporting productivity, budget EUR 120K Year 1, DiGA pathway preferred Germany → India (Bangalore AI health)

SELL Indian telemedicine platform (Apollo 24/7 international) — EU patient second opinion service (cardiology, oncology, orthopaedics), EUR 200–500 per consultation, GDPR SCC ready Mumbai, India → Germany / Netherlands / Portugal

Mandates anonymised. Introduced under NCNDA. Commission on completion. Submit your mandate →

Context & outlook

How this sector is moving.

India ↔ EU FTA impact

Medium-High impact

FTA digital trade chapter confirmation of zero-barrier telemedicine delivery is commercially meaningful. FTA investment chapter full FDI in digital health enables EU companies to own India digital health operations outright (vs earlier joint venture requirements). Regulatory cooperation for CDSCO-MDR alignment could be transformational — if achieved, it would reduce the dual CE + CDSCO certification burden for medical devices trading in both directions.

Essential documents

From the document library.

Doc 11

Data Processing Agreement (GDPR)

DPA + health data Article 9 explicit consent framework — mandatory for digital health mandates

→ Doc 89

EU Medical Device Registration Guide

EU MDR/IVDR class determination and Notified Body selection guide

→

Browse all documents →

Applicable FTAs

FTA

India-EU FTA 2026

Digital trade chapter (telemedicine Mode 1); investment chapter (100% FDI digital health); CDSCO-MDR regulatory alignment discussions

Key markets

Country intelligence for this vertical.

Country

Germany

DiGA reimbursement framework; gematik; largest EU health market; AI health procurement

Country

Netherlands

Philips ecosystem; Dutch health tech; English language; telemedicine early adopter

Country

Portugal

SNS digitalisation plan; accessible EU market entry; Amit Jain presence

All 184 country pages →

Standard operating procedure

SOP-36 · Digital Health Mandate — EU MDR to Commission Protocol

View SOP

Frequently asked

FAQ · Digital Health & HealthTech.

What is the German DiGA (Digitale Gesundheitsanwendungen) framework and how can Indian health apps access it?

DiGA (Digital Health Applications) is Germany's unique reimbursement framework that allows prescribed digital health apps to be reimbursed by all 73 German statutory health insurers (GKV — 70M+ insured patients). Process: (1) Apply to BfArM (Federal Institute for Drugs and Medical Devices) for DiGA listing; (2) Demonstrate positive healthcare effect (clinical evidence — minimum 6-month randomised controlled study or real-world evidence); (3) EU MDR CE marking required for Class IIa or IIb medical device apps; (4) GDPR compliance required; (5) German-language app version; (6) Data stored in Germany or EU. Once DiGA-listed, the app is automatically reimbursed at the negotiated price by all GKV insurers. For Indian health app developers: DiGA is the world's first government-reimbursed digital health framework — a model that France (Mon espace santé) and other EU countries are replicating. Amber-listed DiGA apps (provisional) can be prescribed during evidence generation — reducing the clinical evidence barrier.

Travelogue Forum

Have a question or insight on Digital Health & HealthTech? Start a thread in Markets & Logistics.

Discuss on the Forum →

Explore Further — Across the AJG Network

🧭

From Scope Scape

Authoritative External Sources

Primary + analyst + press

PubMed → Biomedical and life sciences research literature — MEDLINE database 📡 RSS
The Lancet → Leading peer-reviewed medical journal — clinical research, public health 📡 RSS
NEJM — New England Journal of Medicine → Premier US medical journal — clinical trials, drug efficacy, practice guidelines 📡 RSS

🎯

The Guessing Desk

All sources on this topic · filterable

The Guessing Desk — 140 curated sources on "Digital" → Filter the full catalog of 140 authoritative sources and 109 live RSS feeds by this topic. Export to your RSS reader. Th…

Open The Guessing Desk →

Dimension	EU	UAE	USA	UK	ASEAN	AUS
Mkt Size	78	65	90	72	62	60
Growth	90	88	92	90	88	85
Entry Ease	48	72	42	50	68	68
Reg Safety	40	65	38	42	62	65
Mkt Open	52	55	42	52	58	58
Commission	85	82	88	85	72	75
FTA Boost	78	80	40	62	60	70

Supplier Nation	EU Share	Trend	India Edge / Context
USA	28.5%	→	FDA cleared apps
Israel	10.5%	↑	HealthTech
UK	8.5%	→	NHS innovation
India ⭐	3%	↑	—
Germany	7.5%	→	MDD compliance

All factsheets at a glance

Search 23,577,134 allfrontierglobal.com data points

47 Digital Health, HealthTech, Telemedicine and AI Diagnostics — India ↔ EU

What moves on this corridor.

Tariff lines that matter.

Required certifications.

India ↔ EU · the directions.

Risks · assessment · mitigation.

Possibility · probability · plausibility.

The vertical through a 10P lens.

What works · what doesn't.

What works

What doesn't work

How we get paid.

Niches we operate in.

AI Diagnostics (India → EU Radiology)

Telemedicine Second Opinion (India → EU Patient)

German DiGA (Digital Health App — GKV Reimbursable)

India CRO for EU Clinical Trials

What's open right now.

How this sector is moving.

Medium-High impact

From the document library.

India-EU FTA 2026

Country intelligence for this vertical.

Germany

Netherlands

Portugal

FAQ · Digital Health & HealthTech.

Strategic Heat Map

Multilateral Corridor Comparison — Global Overlay

Bilateral vs Multilateral Trade Intelligence

Competitive Intelligence — India vs Competing Nations in the EU Market

Seasonal Trade Calendar

ESG Intelligence & EU Taxonomy Alignment

Supply Chain Resilience Intelligence

RoDTEP Benefit Indicator

India-EU FTA Duty Saving Estimator

Every Direction. Every Configuration. Commission-Only.

Live Digital Health & HealthTech intelligence

📘 Standard operating procedures · 1

📍 Cities tagged with Digital Health & HealthTech · 2

📄 Long-form essays · 2

📰 Recent blog posts · 1

Cron-refreshed data — every cadence

Explore the AJG knowledge graph

Digital Health, HealthTech, Telemedicine and AI Diagnostics — India ↔ EU